In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

ACCA Clinical Decision Making Toolkit

The ACCA Clinical Decision Making Toolkit 2018 edition is now available

One of the best tools to help practitioners make the best bedside clinical decisions, when managing patients with acute cardiovascular diseases.

See more
Be Guidelines Smart

A comprehensive guidelines implementation toolkit especially for Nurses & Allied Professionals. 

See more
Prevention Toolbox

Practical decision-making tools designed to support health professionals and policy makers in their daily practice: HeartScore, HeartQoL and more.

See more

Treatment goals


Patients with IHD

Preventive measures in risk factor control, recommended for patients with ischaemic heart disease, are reviewed, according to the recent 6th Joint Task Force European Guidelines. They require multidisciplinary intervention to succeed in lifestyle changes, as well pharmacological optimization.

Cardio Protective drugs

Correct dosage, interactions, and common side effects of Antiplatelets, ACE inhibitors & ARBs, Betablockers, Statins and Polypill.


Risk factor control

Management of blood pressure; diabetes; lipids; smoking; nutrition; weight and exercise recommendations in secondary prevention.


The ESC Prevention of Cardiovascular Disease programme is supported by AMGEN, AstraZeneca, Ferrer, and Sanofi and Regeneron in the form of educational grants.